Connect
MJA
MJA

What is futile and who decides? The clinician’s dilemma

Bogda Koczwara
Med J Aust 2013; 198 (4): . || doi: 10.5694/mja12.10743
Published online: 4 March 2013

Fictionalised case study: John’s story

John, a 63-year-old farmer, was admitted to the oncology ward for management of extensive oesophageal cancer with chemotherapy and radiotherapy. He lived alone on the farm, was estranged from his wife and saw his adult children infrequently. John had a history of moderate alcohol use and his nutrition had recently declined because of the extensive cancer. A feeding tube was inserted to assist in maintaining nutrition while he was undergoing treatment.


  • Department of Medical Oncology, Flinders Medical Centre, Adelaide, SA.



Competing interests:

No relevant disclosures.

  • 1. Medical Board of Australia. Good medical practice: a code of conduct for doctors in Australia. 2010. http://www.medicalboard.gov.au/Codes-Guidelines-Policies.aspx (accessed May 2012).
  • 2. Montgomery AA, Fahey T. How do patients’ treatment preferences compare with those of clinicians? Qual Health Care 2001; 10 Suppl 1: i39-i43.
  • 3. Thewes B, Meiser B, Duric VM, et al. What survival benefits do premenopausal patients with early breast cancer need to make endocrine therapy worthwhile? Lancet Oncol 2005; 6: 581-588.
  • 4. Sulmasy DP, Terry PB, Weisman CS, et al. The accuracy of substituted judgments in patients with terminal diagnoses. Ann Intern Med 1998; 128: 621-629.
  • 5. Christakis NA, Iwashyna TJ. Attitude and self-reported practice regarding prognostication in a national sample of internists. Arch Intern Med 1998; 158: 2389-2395.
  • 6. Glare P, Virik K, Jones M, et al. A systematic review of physicians’ survival predictions in terminally ill cancer patients. BMJ 2003; 327: 195-198.
  • 7. Christakis NA, Asch DA. Physician characteristics associated with decisions to withdraw life support. Am J Public Health 1995; 85: 367-372.
  • 8. Jennens RR, de Boer R, Irving L, et al. Differences of opinion: a survey of knowledge and bias among clinicians regarding the role of chemotherapy in metastatic non-small cell lung cancer. Chest 2004; 126: 1985-1993.
  • 9. Singer PA, Lowy FH. Rationing, patient preferences, and cost of care at the end of life. Arch Intern Med 1992; 152: 478-480.
  • 10. Bowman KW. Communication, negotiation, and mediation: dealing with conflict in end-of-life decisions. J Palliat Care 2000; 16 Suppl: S17-S23.

Author

remove_circle_outline Delete Author
add_circle_outline Add Author

Comment
Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Online responses are no longer available. Please refer to our instructions for authors page for more information.